Cargando…
Conversion Surgery for Stage IV Gastric Cancer
The prognosis of stage IV gastric cancer (GC) is poor, with palliative chemotherapy remaining the main therapeutic option. Studies increasingly indicate that patients with unresectable stage IV GC, who undergo gastrectomy with radical intention after responding to several regimens of combined chemot...
Autores principales: | Zhang, Fei, Huang, Xuanzhang, Song, Yongxi, Gao, Peng, Zhou, Cen, Guo, Zhexu, Shi, Jinxin, Wu, Zhonghua, Wang, Zhenning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854003/ https://www.ncbi.nlm.nih.gov/pubmed/31788445 http://dx.doi.org/10.3389/fonc.2019.01158 |
Ejemplares similares
-
Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence
por: Zhou, Cen, et al.
Publicado: (2019) -
Statin use and its potential therapeutic role in esophageal cancer: a systematic review and meta-analysis
por: Zhou, Cen, et al.
Publicado: (2019) -
Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review
por: Song, Yongxi, et al.
Publicado: (2020) -
The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials
por: Wu, Zhonghua, et al.
Publicado: (2020) -
The long noncoding RNA CTA‐941F9.9 is frequently downregulated and may serve as a biomarker for carcinogenesis in colorectal cancer
por: Guo, Zhexu, et al.
Publicado: (2019)